Submit A Case CPMS
Home - Network - Working Groups - Rare Disease Working Groups - Hereditary Haemorrhagic Telangiectasia Working Group (HHT-WG) - Clinical Decision Support Tools - Patient Pathways
Hereditary Haemorrhagic Telangiectasia Working Group (HHT-WG)
Introduction Disease Information
Experts & Centers
Experts Centers
Clinical Decision Support Tools
Patient Pathways Do’s and Don’ts Clinical Practice Guidelines Expert Consensus Statements Outcome Measures
Registry
Research
Clinical Trials/Observational Studies Research Publications
Training and Education
E-Learning Pills of Knowledge Webinars
Projects/Initiatives
Based on Evidence European (BEE) Meeting
First Edition BEE Meeting | 25th May, 2023

Patient Pathways

Our Patient Pathways are designed to guide healthcare professionals through the complexities of the care and management of patients with a rare vascular disease, from initial suspicion and diagnosis to treatment, management, and beyond. These pathways aim to:

  • Streamline Diagnosis: Facilitate early and accurate diagnosis through specialized diagnostic criteria and access to expert consultations.
  • Optimize Treatment: Provide comprehensive treatment plans utilizing the latest, evidence-based practices tailored to individual patient needs.
  • Enhance Care Coordination: Ensure seamless coordination between the various healthcare providers, specialists, and support services involved in your care.

Have a look at the HHT pathway below.

Results (2)
Parcours patient pour la Maladie de Rendu Osler
July 11 2017
Patient Pathway for Hereditary Hemorrhagic Telangiectasia
July 11 2017
Skip to content